CCME Global Limited
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from CCME Global Limited's yearly results (2023–2026), compared with Healthcare companies in India. Tap ? on any ratio for what it means.
What stands out
- Shareholder Slice Ratio: Share count rose 248% in 3 years, so each share's slice of the company became smaller. Bigger rise in share count than almost all Healthcare companies in India.
- Steadiness Ratio: Sales grew in 0 of the last 3 years; profit grew in 1 of 3. Less steady than almost all Healthcare companies in India.
- Cash Cushion Ratio: Cash, after subtracting all debt, equals 26% of its market value (net cash). Higher than 97% of Healthcare companies in India.
Cash quality
Profit Cash Ratio
—Data incomplete
Self-Funding Ratio
—Data incomplete
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
0/3 · 1/3Sales grew in 0 of the last 3 years; profit grew in 1 of 3.
Less steady than almost all Healthcare companies in India.
Growth Efficiency Ratio
—Data incomplete
Asset Productivity Ratio
—Data incomplete
Balance-sheet strength
Debt Due Cover Ratio
No debt dueNo debt falls due within a year, according to the latest yearly balance sheet.
Cash Cushion Ratio
+26%Cash, after subtracting all debt, equals 26% of its market value (net cash).
Higher than 97% of Healthcare companies in India.
Tangible Assets Ratio
—Data incomplete
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (10)
CCME Global Limited made a loss over the last year. CCME Global Limited owes ₹0.12 for every ₹1 it owns. CCME Global Limited made a loss in the year to Mar 2026, after a profit the year before.
Compared with Healthcare companies in India · latest annual results Mar 2026.
P/E ratio
LossCCME Global Limited made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
3.59The share price is 3.59 times CCME Global Limited's book value per share, lower than 64% of Healthcare companies in India.
Market cap
₹144 CrThe total market value of all of CCME Global Limited's shares at today's price (share price × number of shares), smaller than 94% of Healthcare companies in India. PosiCap size class: Micro Cap.
Net worth (book value)
₹40 CrWhat CCME Global Limited would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 Mar 2026).
Book value per share
₹8.85Net worth divided by the number of shares. The share price of ₹31.81 is 3.6 times this, which is the P/B above.
Return on equity (ROE)
-1.7%CCME Global Limited lost 1.7% of its shareholders' money over the last year, lower than 95% of Healthcare companies in India.
Owes vs Owns
0.12×CCME Global Limited owes ₹0.12 for every ₹1 it owns (low), lower than 97% of Healthcare companies in India.
Dividend yield
NoneCCME Global Limited does not currently pay a dividend.
Profit growth
LossCCME Global Limited made a loss in the year to Mar 2026, after a profit the year before.
Cash vs debt
Net cashCCME Global Limited held ₹37 Cr more cash than debt (net cash) at Mar 2026.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For CCME Global Limited: ₹144 Cr ÷ ₹40 Cr (31 Mar 2026) = 3.6.
What is CCME Global Limited's return on equity?
CCME Global Limited lost 1.7% of its shareholders' money over the last year, lower than 95% of Healthcare companies in India.
How much does CCME Global Limited owe compared with what it owns?
CCME Global Limited owes ₹0.12 for every ₹1 it owns (low), lower than 97% of Healthcare companies in India.
Does CCME Global Limited pay a dividend?
No. CCME Global Limited does not currently pay a dividend.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.